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Longitudinal in vivo bioimaging 
of hepatocyte transcription factor 
activity following cholestatic liver 
injury in mice
Juliette M. K. M. Delhove1,3, Suzanne M. K. Buckley2, Dany P. Perocheau2, Rajvinder Karda2, 
Patrick Arbuthnot3, Neil C. Henderson4, Simon N. Waddington2,3 & Tristan R. McKay1,5
Molecular mechanisms regulating liver repair following cholestatic injury remain largely unknown. We 
have combined a mouse model of acute cholestatic liver injury, partial bile duct ligation (pBDL), with 
a novel longitudinal bioimaging methodology to quantify transcription factor activity during hepatic 
injury and repair. We administered lentiviral transcription factor activated luciferase/eGFP reporter 
(TFAR) cassettes to neonatal mice enabling longitudinal TFAR profiling by continued bioimaging 
throughout the lives of the animals and following pBDL in adulthood. Neonatal intravascular injection 
of VSV-G pseudotyped lentivirus resulted in almost exclusive transduction of hepatocytes allowing 
analysis of hepatocyte-specific transcription factor activity. We recorded acute but transient responses 
with NF-κB and Smad2/3 TFAR whilst our Notch reporter was repressed over the 40 days of evaluation 
post-pBDL. The bipotent hepatic progenitor cell line, HepaRG, can be directed to differentiate into 
hepatocytes and biliary epithelia. We found that forced expression of the Notch inhibitor NUMB in 
HepaRG resulted in enhanced hepatocyte differentiation and proliferation whereas over-expressing the 
Notch agonist JAG1 resulted in biliary epithelial differentiation. In conclusion, our data demonstrates 
that hepatocytes rapidly upregulate NF-κB and Smad2/3 activity, whilst repressing Notch signalling. 
This transcriptional response to cholestatic liver injury likely promotes partial de-differentiation to allow 
pro-regenerative proliferation of hepatocytes.
The liver has a unique ability to regenerate. Hepatocytes represent approximately 85% of the liver mass, and are 
the major metabolic functional units of the liver. Therefore understanding more about the transcriptional reg-
ulation of hepatocyte biology, both in health and disease, is key to the rational design of new pro-regenerative 
therapies. Partial bile duct ligation (pBDL) in mice is a model of acute cholestatic liver injury, which results in 
increased biliary pressure followed by hepatic injury, inflammation and hepatocyte proliferation1. Cholestasis 
in mice results in the development of a ductular reaction involving neutrophil recruitment, focal zonal necrosis, 
hepatic progenitor cell (HPC) proliferation and differentiation and hepatic stellate cell (HSC) activation to a 
matrix-secreting myofibroblast phenotype (Reviewed in ref. 2). The role of resident macrophage Kupffer cells in 
contentious with depletion experiments in BDL models providing inconclusive data to their role3–5. HSC activa-
tion is known to be via a TGF-β 1 and potentially Notch-dependent mechanism6 whilst NF-κ B signaling is known 
to induce hepatocyte proliferation after liver injury7. Interestingly, Kim et al. have recently shown that NF-κ B 
can itself activate Notch signaling and proliferation in cholangiocytes8. CCN1/integrin-activated NF-κ B leads to 
Jagged1/Notch signaling and proliferation of cholangiocytes after BDL. This mechanism also appears to activate 
HSCs to promote HPC proliferation and differentiation to cholangiocytes. Application of soluble JAG1 after 
BDL has been shown to reduce hepatic necrosis and ductular reaction8. Furthermore, following hepatic injury 
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Wnt3a secretion from macrophages maintains the expression of the Notch inhibitor, Numb, in HPCs promoting 
their differentiation to hepatocytes9. A complex inter-relationship is emerging, which involves intracellular and 
paracrine signaling, controlling cell mobilization, proliferation and fate decisions in a context-dependent manner 
during liver development, homeostasis and injury.
We have developed an in vivo platform for quantifying hepatocyte transcription factor activity in live mice. 
We used lentiviral transcription factor activated reporter cassettes (TFAR) co-expressing firefly luciferase and 
eGFP. Conditional control of reporter gene activity by a synthetic promoter enabled longitudinal analysis of 
transcription factor activity profiles by continued bioimaging in mice following pBDL. Intravascular injection 
of VSV-G pseudotyped lentiviruses into newborn mice resulted in almost exclusive transduction of hepatocytes, 
which allowed analysis of hepatocyte-specific transcription factor activity. This has enabled us to longitudinally 
assess hepatocyte NF-κ B, Smad 2/3, Notch and Wnt signaling activity in vivo following pBDL. We then combined 
TFAR bioimaging with complementary immunohistochemistry and in vitro evaluation of hepatic progenitor cell 
(HepaRG cells) differentiation to provide new insights into the temporal transcriptional activity and signaling 
mechanisms that mediate the hepatic injury and repair response during cholestatic liver injury.
Results
Lentiviral transduction is restricted largely to hepatocytes after intravenous administration to 
neonatal mice. Here we report, for the first time, that intravenous administration of VSV-G pseudotyped 
lentivirus constitutively expressing FLuc/eGFP in P0 mouse neonates results in efficient liver-restricted hepato-
cyte transduction (Fig. 1A and B) that is maintained for over 100 days10. Bile duct ligation is an established model 
for initiation of the ductular reaction. However, complete occlusion of the common bile duct in mice can result 
in severe hepatic injury, liver failure and mortality. Partial bile duct ligation (pBDL) can be achieved by either a 
partial occlusion of the common bile duct11 or a complete occlusion of the ducts draining the median and left 
liver lobes leaving the right and caudate lobes fully functional12 and therefore we used pBDL throughout this 
study. Following pBDL, we observed bile duct dilatation, biliary hyperplasia, and mononuclear cell infiltrate 
characteristic of portal tract ductular reaction (Fig. 2Ai and ii). Furthermore, an increase in collagen deposition 
was observed following pBDL (Fig. 2Bi and ii).
We initially administered a VSV-G pseudotyped lentivirus constitutively expressing FLuc/eGFP from the 
SFFV promoter to neonatal mice, which upon maturity, were subjected to pBDL or sham surgery followed by 
continued luciferase bioimaging. There was no difference in luciferase activity between pBDL and sham-treated 
animals. Similarly there was no change in reporter activity for up to 40 days post pBDL (Fig. 3A). Mice were sacri-
ficed 90 days later to correlate lentiviral transduction with liver pathology at the cellular level. Intravenous admin-
istration of lentivirus resulted in up to 49% GFP positive hepatocytes. The vast majority of cells stably expressing 
eGFP 90 days post-pBDL were HNF4α + hepatocytes (Fig. 3Bi–iii) Areas of ductular reaction were distinctly 
lacking in GFP expression. Furthermore GFP expression did not co-localise with markers of cholangiocytes 
(CK7, Fig. 3Ci–iii), hepatic progenitor cells (HPC – PKM2, Fig. 3Di–iii), myofibroblasts (α -SMA, Fig. 3Ei–iii) 
or quiescent hepatic stellate cells (HSC – GFAP, Fig. 3Fi–iii).
Hepatocyte specific TFAR activity after pBDL in adult mice. In this study we used our pre-
viously described liver-targeted transcription factor activated reporter (TFAR) cassettes10 to investigate 
hepatocyte-specific signalling during acute cholestatic liver injury. We have previously generated a library of 
lentiviral TFAR where serial transcription factor consensus sites are engineered upstream of a minimal pro-
moter sequence driving a bicistronic firefly luciferase (FLuc)/eGFP reporter cassette (Fig. 4A). For this study we 
employed TFARs that were specific for four cell signalling pathways implicated in responses to cholestatic liver 
injury: NF-κ B, TGF-β (Smad2/3), Wnt (TCF/LEF) and Notch. We initially validated each TFAR for activation 
over 72 h in HEK293T cells. NF-κ B, TGF-β and Wnt were all responsive to their respective agonists (LPS, Activin 
Figure 1. Neonatal intravascular administration of lentiviral vectors targets the liver and overwhelmingly 
transduces hepatocytes. Lentivirus constitutively expressing FLuc and GFP (LNT-SFFV-FLuc/eGFP) was 
administered to P1 neonatal mice by intravascular injection. Mice were sacrificed after 90 days and liver 
sections immunostained with GFP antibody. (A) GFP expression was overwhelmingly evident in hepatocytes 
compared to (B) controls (n = 3 both groups).
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A and LiCl2 respectively) (Fig. 4B–D) and Notch TFAR transduced cells were responsive to co-culture with JAG1 
over-expressing 293 T cells in a dose dependent manner (Fig. 4E).
In vivo transcription factor activity analysis was performed by neonatal administration of lentivirus contain-
ing the biosensing TFAR. Signalling pathway activation during disease induction was then quantified as photonic 
output (schematically represented in Fig. 5A). Having shown that lentiviral transduction is almost exclusively 
hepatocyte-specific and maintained in daughter cells because of stable genomic integration of the expression cas-
sette, we can assume that the expansion of FLuc/eGFP expression we observe during development is largely from 
hepatocytes. Our data generated using a constitutively activated GFP also suggest that following pBDL, most of 
the resident hepatocyte population survives and remains stable during liver remodelling post pBDL.
We next carried out longitudinal luciferase bioimaging in mice containing each of the four TFAR (NF-κ B, 
TGF-β (Smad2/3), Wnt (TCF/LEF) and Notch) following pBDL at 49–60 days post-birth. We observed an acute 
NF-κ B response immediately after pBDL which was not apparent in sham operated controls (Fig. 5Bi and ii). 
Control mice were subjected to laparotomy to correct for any paracrine inflammatory response consequent to the 
abdominal surgery. Interestingly, in a number of the sham treated mice an NF-κ B response in hepatocytes above 
baseline was observed that quickly diminished (Supplementary Fig. 1). This would be consistent with a systemic 
inflammatory response to the laparotomy. The NF-κ B response peaked 10 days after pBDL and decreased to 
baseline by 24 days. This was revealed by a more than 28-fold increase in NF-κ B activity following pBDL when 
compared to controls, as revealed by analysis of the area under curve. A similar statistically significant, but less 
pronounced, response was seen with the TGF-β activated Smad2/3 TFAR at the same timepoints (Fig. 5Ci and ii). 
Collectively, these data demonstrate that hepatocytes are important “primary responders” to inflammatory and 
fibrotic stimuli following biliary injury.
The Notch and Wnt pathways have been implicated in regeneration and repair after hepatic injury9. To analyse 
the role of these pathways following pBDL, adult liver targeted TFAR mice were assessed by continued bioimag-
ing as before. The Notch TFAR mice showed a prolonged and significant decrease in luciferase reporter activity 
in pBDL compared to sham-treated animals (Fig. 6Ai and ii) but the Wnt activated TCF/LEF TFAR showed no 
significant change in activity (Fig. 6Bi and ii). Histological assessment of activated NICD and β -catenin showed 
largely membrane-bound localization in cholangiocytes in sham and pBDL-treated mice (Fig. 6C and D). 
Collectively, these data indicate that hepatocyte Notch transcription factor activity is decreased following pBDL, 
and notch signalling is localized to the bile ducts in normal and hyperplastic livers after pBDL. It is possible that 
hepatocytes inhibit Notch signals that are emanating from hyperplastic bile ducts in pBDL livers.
Interrogation of Wnt and Notch signalling in differentiated HepaRG cultures. To interrogate 
the interactions of hepatocytes and cholangiocytes we exploited the bipotent nature of the HepaRG cell line. 
Bipotent HepaRG progenitors were subjected to a differentiation protocol previously described by Dianat et al.13. 
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Figure 2. Partial bile duct ligation results in liver remodelling and collagen deposition in occluded lobes. 
Adult mice were subjected to partial bile duct ligation and sacrificed after 90 days. Control livers from sham 
operated mice (Ai) and occluded pBDL livers (Aii) were fixed, sectioned and stained with Hematoxylin & Eosin 
for histological architecture and Lilly’s trichrome (Bi & ii) staining collagen (blue), nuclei (black) and cytoplasm 
(red). Bile duct (bd), portal vein (pv), biliary hyperplasia (bh), ductular reaction (dr), (n = 3 both groups).
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Figure 3. Reporter gene expression is stable and restricted to hepatocytes after pBDL following neonatal 
intravascular administration of lentiviral vectors. SFFV-FLuc/eGFP lentivirus was administered to P1 
neonatal mice by intravascular (i.v.) injection and then subjected to pBDL or sham pBDL in adulthood. (A) 
Mice were subjected to continued luciferase bioimaging over 40 days where no change in luciferase activity was 
observed over time or between pBDL and sham groups (n = 10 pBDL, 5 sham, not significant, Student’s t-test). 
Mice were sacrificed 90 days after pBDL and co-immunostained for GFP and markers of (Bi-iii) hepatocytes; 
HNF4α , (C-iii) biliary epithelia; CK7, (Di-iii) hepatic progenitors; PKM2, (Ei-iii) myofibroblasts; α SMA and 
(Fi-iii) hepatic stellate cells; GFAP (all groups n = 3–6).
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The protocol was developed to differentiate HepaRG to cholangiocytes but in our hands it reproducibly gen-
erated CK19+ cholangiocyte cultures interspersed with colonies of HNF4α +/ALB+ hepatocytes (Fig. 7Ai–iv). 
In agreement with our evaluations in vivo, we observed widespread membrane-bound β -catenin staining in 
CK19-positive cholangiocytes and interestingly, increased NICD staining at the interface between cholangio-
cytes and the hepatocyte colonies (Fig. 7Av and vi). We compared the effects of modulating Notch signalling by 
transducing HepaRG cells with lentiviruses constitutively expressing the Notch inhibitor NUMB (HepaNumb) 
or the Notch ligand JAG1 (HepaJag) before subjecting them to our differentiation protocol. There was a sig-
nificantly higher total area of hepatocyte-like colonies in HepNumb cultures (36.94%, n = 14) compared to 
HepaJag (22.05%, n = 12) (Fig. 7Bi and ii). The transgenes were expressed from a bicistronic lentiviral cassette 
co-expressing GFP from a truncated CMV promoter and transduction efficiencies ranged between 50 and 80%. 
Interestingly, we did not observe Jag1/GFP expression in any hepatocyte-like colonies (Fig. 7Ci and ii). We imply 
from these data that hepatocyte differentiation can only occur in HepaRG cells when Notch activity is repressed. 
This is consistent with increased hepatocyte colony formation in Numb transduced HepaRG cultures.
Discussion
Bile duct ligation in rodents results in acute cholestasis and a ductular reaction with upregulation of inflamma-
tory and pro-fibrotic signalling14. Complete ligation of the common bile duct causes high rates of mortality but 
partial bile duct ligation (pBDL), occluding the ducts draining the left and median lobes, results in localized 
cholestasis that is amenable to longer-term analysis15. NF-κ B and TGF-β 1 signaling are prominent in promoting 
responses to liver injury such as myofibroblastic differentiation and ECM remodelling16,17. Although the role of 
TGF-β signaling is well characterised in HSC, activity in hepatocytes after liver injury is less clear. Two previous 
studies have indicated that following liver injury TGF-β signalling emanates from hepatocytes but neither present 
a longitudinal analysis17,18. We sought to investigate longitudinal transcription factor activity in vivo using biolu-
minescence imaging in live mice subjected to pBDL. A constitutively activated eGFP reporter was used to assess 
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Figure 4. In vitro validation of transcription factor activated lentiviral reporter vectors. (A) Schematic 
representation of parental lentiviral reporter construct. (B–E) 293 T cells were transduced with VSV-G 
pseudotyped TFAR lentiviral vectors at an MOI of 10 then incubated with the relevant agonists and luciferase 
expression quantified at 12, 24, 48 and 72 h (n = 3–6, mean+ /− SEM, comparison by analysis of variance with 
repeated measures).
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the distribution of lentiviral transduction > 90 days post-transduction. In line with our previous observations, 
transduction was largely restricted to the liver but, unexpectedly, histological analysis revealed that transduced 
cells within the liver were almost exclusively hepatocytes. Specifically, we observed no evidence of cholangiocyte, 
HSC or HPC transduction pre- or post-BDL inferring that we were not transducing bi-potent progenitor cells. 
This provided us with a unique tool to assess transcription factor activity specifically in hepatocytes subsequent 
to pBDL.
Bile duct ligation results in an acute phase inflammatory response leading to necrosis19 caused directly by bile 
acid reflux20 and other deregulated factors such as osteopontin21. There is strong evidence from mice that NF-κ B acti-
vation during this inflammatory phase promotes hepatocyte proliferation in vivo following partial hepatectomy7,22. 
In hepatocytes we saw an acute increase in both NF-κ B and Smad2/3-mediated luciferase activity after pBDL, 
peaking at around 10 days post-BDL before returning to pre-pBDL levels at 28 days. Interestingly, NF-κ B and 
Smad2/3 responses returned to pre-pBDL levels within the same timeframe, whereas it is known that liver fibrosis 
in partial BDL models progresses over many months23. This would suggest that compensatory factors restore a 
homeostatic balance to reduce damage and maintain function despite chronic disease. This would be consistent, 
for example, with Smad7 upregulation repressing Smad2/3 responses despite continued expression of TGF-β 117. 
Although the role of TGF-β signalling in hepatocytes is not clearly understood it is well established that TGF-β 
promotes the ductular reaction in BDL rats by promoting cholangiocyte proliferation in an α vβ 6-integrin spe-
cific manner24,25. Our data is the first hepatocyte-targeted description of NF-κ B and Smad2/3 activated luciferase 
reporter bioimaging in a rodent pre-clinical model of acute cholestatic liver injury.
Notch signalling is established as playing a significant role in bile duct development where the Notch ligand 
JAG1 promotes cholangiocyte differentiation of bi-potent HPCs26. NF-κ B and Notch signalling have been linked 
Figure 5. pBDL causes transient activation of NFB and Smad2/3 transcription factor activity. (A) Cartoon 
of the principles underlying somatotransgenic bioimaging. Lentiviruses expressing transcription factor 
activated reporter (TFAR) constructs expressing luciferase and GFP are administered to neonates. When they 
reach adulthood baseline luciferase expression is assessed before inducing a disease state, in this case by pBDL. 
Continued luciferase bioimaging provides a quantifiable surrogate for nuclear localization and target DNA 
binding of transcription factors. Somatotransgenic mice were generated as described then subjected to pBDL 
or sham pBDL and luciferase activity assayed over 30 days. (Bi & ii) NFκ B and (Ci & ii) Smad2/3 TFAR activity 
showed significant increases as assessed by area under the curve analysis (NFκ B, n = 13 pBDL, n = 6 sham; 
p < 0.0001; Smad2/3, n = 9 pBDL, n = 9 sham, p < 0.05, Student’s t-test).
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during HPC commitment to cholangiocytes during the ductular reaction in mice8, and also to the severity of 
human hepatic fibrosis6 but never related specifically in hepatocytes after pBDL. Haploinsufficiency at the locus 
encoding the Notch ligand JAG1 results in Alagille syndrome characterised by impaired intrahepatic bile duct 
development and widespread ductular reaction. There is no obvious effect on hepatocytes27 and Notch inhibition 
by Wnt3a-mediated Numb upregulation in HPCs results in hepatocyte specification9. Our longitudinal assess-
ment indicated that Notch signalling is actually inhibited in hepatocytes over 50 days post-pBDL whilst there is 
no change in Wnt-mediated TCF/LEF activity throughout a similar timecourse. Immunohistochemistry showed 
that both β -catenin and NICD present in cholangiocytes but largely absent from hepatocytes. The absence of 
NICD in hepatocytes is consistent with upstream inhibition of Notch receptor cleavage as protection from per-
petuating Notch signalling emanating from the ductular reaction.
Transduction of the bi-potent hepatic progenitor cell line HepaRG with lentiviruses constitutively express-
ing Numb or JAG1 further corroborates this hypothesis. Numb over-expression resulted in an increase in the 
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Figure 6. pBDL causes repression of Notch signalling. Mice somatotransgenic for liver specific expression of the 
Notch and Wnt (TCF/LEF) TFAR were subjected to pBDL or sham surgery. There was significant repression of the 
(Ai & ii) Notch TFAR over 40 days pBDL compared to sham control analysed by area under the curve comparison 
(n = 10 pBDL, n = 5 sham; p < 0.05, Student’s t-test) but no significant change in (Bi & ii) Wnt TFAR activity (n = 8 
pBDL, n = 5 sham, not significant, Student’s t-test). Immunohistochemistry of liver sections 90 days after pBDL 
showed an increase in the number of (C) NICD positive and (D) β -Catenin positive bile ducts in pBDL compared 
to sham (n = 3).
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frequency and size of ALB+/HNF4α + clusters seen within differentiated cultures compared to controls, indicat-
ing that reduced Notch signalling confers a propensity for cells to differentiate towards the hepatocyte lineage. 
Differentiated HepaRG cultures over-expressing JAG1 had less hepatocyte-like colonies. Interestingly, bi-potent 
HepaRG transduced with the JAG1-GFP expressing lentivirus were unable to differentiate to hepatocyte colonies. 
It is possible that this observation is a result of differential methylation of the CMV promoter in hepatocytes com-
pared to cholangiocytes, or that hepatocyte differentiation is not possible in the presence of JAG1. With either 
situation hepatocyte-like colonies do not have exogenous JAG1 expression. There is some evidence that Notch 
inhibition promotes hepatocyte proliferation and in some cases metastases28,29 implying hepatocytes are intrin-
sically resistant to Notch signalling30. The emerging consensus is that regenerative hepatocyte proliferation after 
acute liver injury does not emanate from progenitors residing within the canal of Hering31. Overall, our novel data 
highlights the use of longitudinal luciferase bioimaging in monitoring cell-type specific transcriptional activity 
in live animals. This has enhanced our understanding of the temporal activity profiles of the core transcriptional 
networks involved during acute cholestatic liver injury and repair.
Figure 7. Modulation of Notch signalling influences the differentiation of bipotent HepaRG cells. 
HepaRG cells subjected to differentiation conditions formed (Ai) tight colonies that immunostained positive 
for the hepatocyte markers (Aii) HNF4α and (Aiii) Albumin whereas the surrounding cells immunostained 
positive for the biliary epithelial marker (Aiv) CK19 and (Av) β -Catenin. The interface between colonies and 
surrounding cells immunostained positively for (Avi) NICD. Bipotent HepaRG cells were transduced with 
lentiviral constructs expressing Numb or Jag1/GFP then subjected to differentiation conditions. We observed a 
greater area of hepatocyte-like colonies in (Bi) HepaRG-Numb cells compared to (Bii) HepaRG-Jag1/GFP cells 
as quantified by total area ImageJ software. In HepaRG-Jag1/GFP cultures dual immunocytochemistry revealed 
that (Ci) GFP and CK7 co-localized but (Cii) GFP and Albumin never co-localized.
www.nature.com/scientificreports/
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Methods
Construction and production lentiviral reporter vectors. The NF-κ B, SMAD2/3, Notch and Wnt 
(TCF/LEF) TFAR lentiviral vector cassettes were previously described in Buckley et al.10.
HEK293T viral producer cells were seeded at 2 × 107 cells per T175 cm2 flask and transfected using 50 μ g 
pLNT-TFBE-JDG, 17.5 μ g pMD2.G (VSV-G envelope plasmid), and 32.5 μ g pCMVΔ R8.74 (gag-pol packaging 
plasmid) pre-complexed with 1 μ l polyethylenimine (10 mM) (Sigma-Aldrich) in OptiMEM for 3 h. Transfection 
media was replaced with complete DMEM and viral supernatant collected at 48 and 72 hours, filter sterilized 
(0.45 μ M), and concentrated by overnight low-g centrifugation. Pellets were resuspended in OptiMEM and stored 
at − 80 °C. All viruses were titered using a p24 assay (Zeptometrix, Buffalo, NY, USA) as per manufacturer’s 
instructions.
In vitro validation of reporter gene activity. HEK293T, HeLa and NIH3T3 cells were cultured in DMEM 
supplemented with 10% FBS, 1% penicillin/streptomycin (Sigma), 2mM L-glutamine and 1x non-essential amino 
acids. HepaRG cells were cultured in William’s E medium containing Glutamax and sodium pyruvate supple-
mented with 10% FBS, 1% Pen/Strep, 1x non-essential amino acids, 4 μ g/ml human recombinant insulin zinc 
solution, and 50 μ M hydrocortisone. All reagents were sourced from Life Technologies.
For the in vitro validation of NF-κ B, SMAD2/3 and Wnt (TCF/LEF) TFAR, cells were transduced with VSV-G 
pseudotyped lentivirus reporters at an MOI of 10. Small molecule or growth factor agonists or inhibitors were 
used for reporter functional validation. The trophoblast-isolated SGHPL5 cell line was transduced with a Notch 
reporter lentivirus to validate this vector. Varying seeding densities of JAGGED-1-overexpressing HEK293T cells 
were used to activate the Notch-SGHPL5 cells. Analysis was performed following 72 hours of co-culture.
Gene activation was quantified by luciferase assay on cell lysates as follows: 20 μ l assay buffer (25 mM Tris 
phosphate pH 7.8, 1 mM DTT, 1 mM EDTA, 1% Triton X-100, 8 mM MgCl2, 3 ml glycerol, 1.25 mM rATP, 0.5% 
BSA) was added to 20 μ l cell extract. Luciferin (Gold Biotechnology, MO, USA) was added to a final concentration 
of 1.5 mM and luminescence measured using the POLARstar Omega microplate reader (BMG Labtech). Analysis 
performed using MARS data analysis software (BMG Labtech). Relative light units were normalized relative to 
total protein as determined by Bradford assay (BioRad) using manufacturer’s instructions.
Differentiation of HepaRG cells. HepaRG cells were seeded at low density and maintained in William’s E 
medium containing 10% FBS, 1x non-essential amino acids, hydrocortisone (50 μ M) and insulin (4 μ g/ml). Cells 
were plated onto collagen-coated plates and allowed to grow to confluency prior to chemical induction. Confluent 
cells were treated with IL-6 (10 ng/ml) (R&D Systems) for 2 days, followed by 2 days of sodium taurocholate 
hydrate (10 nM) (Sigma) treatment, and a further 8 days of sodium taurocholate hydrate (10 nM) (Sigma) and 
sodium butyrate (1.8 μ M) (Sigma) treatment.
Immunocytochemistry. Media was removed and cells washed 3x in PBS. Cells were fixed in 4% para-
formaldehyde (PFA) (Sigma) for 20 minutes followed by three washes in PBS. Cells were incubated in blocking 
buffer (PBS, 0.3% Triton X-100, 1% BSA) for one hour at room temperature before the addition of primary 
antibody (Table 1) resuspended in blocking buffer was added to the cells and incubated overnight at 4 °C. Cells 
were washed three times in PBS for 5 minutes followed by incubation at room temperature for 1 hour with 
fluorophore-conjugated secondary antibody resuspended in blocking buffer. Cells were washed 3x in PBS and 
incubated in 1 × 4′,6-diamidino-2-phenylindole (DAPI)(Sigma) in PBS for 5 minutes before being washed 3x in 
PBS for 5 minutes. Cell F imaging software was used for all analysis.
Animal procedures. Unless otherwise stated, outbred CD1 mice (Charles River) were time mated to pro-
duce neonatal animals. At postnatal day 1, neonates were briefly anesthetized (on ice) and lentivirus injected by 
intravenous (via the superficial temporal vein) injection.
All experiments were performed in accordance with relevant guideless and regulations: Experiments were 
carried out under United Kingdom Home Office regulations and approved by the ethical review committees of 
Imperial College London and University College London.
Antibody Supplier Dilution
Mouse α CK19 Dako (M0888) 1:200
Mouse α CK7 Sigma (4465 P) 1:200
Mouse α HNF-4α Perseus (PP-H1415–00) 1:200
Mouse α ALB R&D Systems (MAB1455) 1:200
Goat α Sox9 R&D Systems (AF3075) 1:500
Rabbit α NICD Abcam (ab8925) 1:200
Rabbit (active) β -catenin New England Biolabs (8814 S) 1:200
Rabbit α -goat Alexafluor Life Technologies (A11079) 1:500
Goat α -rabbit Alexafluor Life Technologies (A11011) 1:500
Goat α -mouse Alexafluor Life Technologies (A11031) 1:500
DAPI Sigma Adlrich (D9542) 1:1000
Table 1.  Primary and secondary antibody information used for immunocytochemistry.
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Partial bile duct ligation in mice. At 49 (SFFV), 50 (NF-κ B, Wnt, Notch), or 60 (Smad 2/3) days 
post-birth, mice were anaesthetized with isoflurane (Abbott Laboratories) and a midline laparotomy (≈ 15 mm) 
performed just caudal to the sternum. The median and left lobes of the liver were exteriorized and kept moist with 
sterile gauze. The bile duct was ligated with 6–0 silk suture to occlude outflow from the left and median lobes but 
not occluding bile outflow from the right and caudate lobes as described by Yang and colleagues32. The liver was 
returned to the abdomen and the wound closed in two stages using 6–0 silk suture; skin was closed using a sub-
cuticular suture with buried knots. Sham operated mice received laparotomy only. Mice were allowed to recover 
in a warmed chamber. Pre- and post-operative buprenorphine analgesia was provided.
Bioluminescence imaging. Unless otherwise stated, mice were anaesthetized with isoflurane (Abbott 
Laboratories), injected i.p. with firefly D-luciferin (15 mg/ml in PBS; Gold Biotechnology) and imaged 5 min 
later with a cooled charge-coupled device (CCCD) camera (IVIS; PerkinElmer). Luciferin dose was 150 mg/kg; 
volume varied with age/size of animal, for example, adult mice were given 300μ l. Grey-scale photographs were 
acquired with a 24-cm field of view and then a bioluminescence image was obtained using a binning (resolution) 
factor of 4, a 1.2/f stop and open filter. Regions of interest (ROIs) were defined manually using a standard area 
for each organ under investigation. Signal intensities were calculated with Living Image software (Perkin Elmer) 
and expressed as photons per second per cm2 per steradian. Where possible, BLI was carried out in adult reporter 
rodents on three consecutive days to establish a robust median baseline; subsequent data points were expressed 
as fold-change over this internal standard for each individual animal.
Immunohistochemistry. Liver tissue was fixed in 10% formalin overnight, dehydrated using 70%, 80%, 
90% and 2 × 100% ethanol for 1 hour each followed by Histoclear (National Diagnostics) overnight. Samples 
were embedded in Fibrowax (VWR). Tissue sections were cleared twice in Histo-clear for 10 minutes each, and 
brought to water using 90%, 70%, and 50% IMS, followed by 5 minutes in distilled water. Antigen retrieval was 
performed in 10 mM citrate buffer (pH6.0)(Sigma-Aldrich) or 10 mM Tris HCL for 40 or 10 minutes respectively 
and cooled for 20 minutes. Samples were incubated for 10 minutes in TBS containing 0.3% Triton X-100 (TBS-T) 
followed by blocking in TBS-T + 15% normal goat serum (NGS) (Vector laboratories) for 1 hour at room temper-
ature. Primary antibody (see Table 2) was diluted in TBS-T/10% NGS overnight at 4 °C. Slides were rinsed thrice 
for 5 minute in TBS followed by incubation in secondary antibody diluted in TBS-T/10% NGS for 1 hour at room 
temperature. Samples were washed thrice for 5 minutes in TBS before incubation with 0.3% Sudan Black B made 
up in 70% ethanol for 15 minutes at room temperature. Sections were rinsed thrice with TBS for 5 minutes and 
mounted using Fluorescence Mounting Medium (Dako). Images in several fields were quantified using ImageJ 
software as outlined by Wang et al.33. Images were subjected to thresholding to determine true GFP expression 
over background with pixels between background level (79) and the maximum (255) considered positive. Positive 
pixels as a percentage of total image pixels were used to determine total area of GFP positive regions.
H&E and Lilley’s trichrome staining. Histological sections were brought to water as previously described 
before being placed in Weigert’s haematoxylin for 5 minutes and then rinsed in running water. Differentiation, 
or selective stain removal was performed by incubating the slides in acid alcohol (70% EtOH with 0.5% HCl) 
for approximately 10. Sections were rinsed in water and subsequently stained in eosin for 5 minutes. This was 
followed by rapid dehydration by passing through 70%, 90% and 100% alcohol for 2–3 seconds followed by a final 
100% alcohol bath for 5 minutes. Incubation in 2 baths of Histo-clear for 10 minutes each was performed dry 
before mounting with Histomount (Sigma).
Lilley’s trichrome staining. Histological sections were brought to water as in protocol above, incubated 
in Weigert’s haematoxylin for 5 minutes and rinsed in distilled water. Slides were placed in working strength 
picric acid solution for 10 minutes, washed in distilled water, and stained in Xylidine Red solution (Sigma) for 
1 minute and rinsed in distilled water. Differentiation was performed using a 1% phosphomolybdic acid bath for 
10 minutes. Collagen staining was achieved by subsequently staining slides in Aniline Blue solution (Sigma) for 
1 minute before being placed in fresh 1% phosphomolybdic acid for 2 minutes and 1% acetic acid for 3 minutes 
prior to rapid dehydration of samples in 95% and 2 × 100% alcohol. Slides were cleared in 2 baths of Histoclear 
for 10 minutes each before mounting with Histomount.
Antibody Supplier Antigen Retrieval Dilution
Chicken α GFP NEB (13970) Na Citrate (pH6) 1:300
Mouse α CK7 Perseus (PP-H415-00) Na Citrate (pH6) 1:200
Mouse α HNF-4α Dako (M0851) Tris HCl (pH10) 1:100
Rabbit α SMA Dako (Z0334) Na Citrate (pH6) 1:200
Rabbit α GFAP Dako (M7018) Tris HCl (pH10) 1:500
Rabbit α -PKM2 Life Technologies (PA5-23034) Na Citrate (pH6) 1:200
Goat α -rabbit Alexafluor Life Technologies (A-11011) 1:500
Goat α -mouse Alexafluor Life Technologies (A-11031) 1:500
Goat α -chicken Alexafluor R&D Systems (NL018) 1:400
DAPI Sigma Aldrich (D9542) 1:1000
Table 2.  Primary and secondary antibodies used for immunohistochemistry.
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Statistical analysis. Statistical analysis on in vitro vector analysis data was performed using an unpaired 
Student’s one-tailed t-test. All data are expressed as mean values ± SEM, with each sample being measured at 
least in triplicate. For in vivo data, repeated measurements were analyzed with repeated measures analysis of var-
iance with significance level of p < 0.05. Area under curve data for experiments with two groups was analyzed by 
Student’s one-tailed t-test. For areas under curve derived from two or more groups, one-way analysis of variance 
with Newman-Keuls post-hoc multiple comparison test was performed.
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